Tirzepatide – 10 vials
Tirzepatide – 10 vials (TR5) is a new medication that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is used in the treatment of type 2 diabetes and is currently being studied to evaluate its potential benefits in weight management. Available in multiple dosages:
Specifications
- Concentration
- 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 100mg
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
68%